As of 2024-12-15, the Relative Valuation of Trellus Health PLC (TRLS.L) is (24.11) GBP. This relative valuation is based on P/E multiples. With the latest stock price at 0.63 GBP, the upside of Trellus Health PLC based on Relative Valuation is -3957.4%.
The range of the Relative Valuation is (22.82) - (25.89) GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 7.0x - 8.4x | 7.7x |
| Forward P/E multiples | 6.2x - 7.9x | 7.0x |
| Fair Price | (22.82) - (25.89) | (24.11) |
| Upside | -3750.8% - -4242.5% | -3957.4% |
| Date | P/E |
| 2024-11-29 | -0.15 |
| 2024-11-28 | -0.15 |
| 2024-11-27 | -0.16 |
| 2024-11-26 | -0.16 |
| 2024-11-25 | -0.16 |
| 2024-11-22 | -0.16 |
| 2024-11-21 | -0.16 |
| 2024-11-20 | -0.17 |
| 2024-11-19 | -0.16 |
| 2024-11-18 | -0.16 |
| 2024-11-15 | -0.16 |
| 2024-11-14 | -0.16 |
| 2024-11-13 | -0.16 |
| 2024-11-12 | -0.16 |
| 2024-11-11 | -0.16 |
| 2024-11-08 | -0.16 |
| 2024-11-07 | -0.16 |
| 2024-11-06 | -0.16 |
| 2024-11-05 | -0.16 |
| 2024-11-04 | -0.16 |
| 2024-11-01 | -0.16 |
| 2024-10-31 | -0.16 |
| 2024-10-30 | -0.16 |
| 2024-10-29 | -0.16 |
| 2024-10-28 | -0.16 |
| 2024-10-25 | -0.16 |
| 2024-10-24 | -0.16 |
| 2024-10-23 | -0.16 |
| 2024-10-22 | -0.16 |
| 2024-10-21 | -0.16 |
| 2024-10-18 | -0.17 |
| 2024-10-17 | -0.15 |
| 2024-10-16 | -0.18 |
| 2024-10-15 | -0.20 |
| 2024-10-14 | -0.21 |
| 2024-10-11 | -0.21 |
| 2024-10-10 | -0.21 |
| 2024-10-09 | -0.21 |
| 2024-10-08 | -0.23 |
| 2024-10-07 | -0.23 |
| 2024-10-04 | -0.23 |
| 2024-10-03 | -0.23 |
| 2024-10-02 | -0.23 |
| 2024-10-01 | -0.22 |
| 2024-09-30 | -0.24 |
| 2024-09-27 | -0.25 |
| 2024-09-26 | -0.25 |
| 2024-09-25 | -0.35 |
| 2024-09-24 | -0.28 |
| 2024-09-23 | -0.28 |